Page last updated: 2024-08-21

dihydroergotamine and sumatriptan

dihydroergotamine has been researched along with sumatriptan in 102 studies

Research

Studies (102)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.98)	18.7374
1990's	58 (56.86)	18.2507
2000's	27 (26.47)	29.6817
2010's	16 (15.69)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamblin, MW; Metcalf, MA	1
Adham, N; Bard, JA; Branchek, TA; Vaysse, P; Weinshank, RL; Zgombick, J	1
Arrang, JM; Diaz, J; Leurs, R; Ruat, M; Schwartz, JC; Tardivel-Lacombe, J; Traiffort, E	1
Izzarelli, DG; Lewis-Higgins, L; Palmer, D; Parker, EM; Shapiro, RA	1
Gommeren, W; Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van de Weyer, I; Van Gompel, P; Vanhoenacker, P; Wouters, R	1
Boess, FG; Monsma, FJ; Sleight, AJ	1
Audia, JE; Krushinski, JH; Lucaites, VL; Nelson, DL; Schaus, JM; Wainscott, DB; Zgombick, JM	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Diener, HC; Grotemeyer, KH; Pfaffenrath, V; Soyka, D	1
Liaño, H	1
Buzzi, MG; Dimitriadou, V; Moskowitz, MA; Theoharides, TC	1
Boccalini, P; Moskowitz, MA; Nozaki, K	1
den Boer, MO; Saxena, PR; Somers, JA	1
Ollat, H	1
Buzzi, MG; Moskowitz, MA	2
Deliganis, AV; Peroutka, SJ	1
Goadsby, PJ; Jauslin, P; Lance, JW	1
Buzzi, MG; Carter, WB; Heath, H; Moskowitz, MA; Shimizu, T	1
den Boer, MO; Heiligers, JP; Saxena, PR	1
McCarthy, BG; Peroutka, SJ	1
Titus, F	3
Alberca, R; Arenas, C; Casado, JL; Moreno, A; Serrano, V	1
Ferrari, MD; Haan, J	1
Wilkinson, M	1
Lipton, RB; Silberstein, SD	1
Kumar, KL	1
Bax, WA	1
Landy, S; Lobo, BL	1
d'Allens, H; Henry, P	1
Solomon, GD	1
Bax, WA; Ferrari, MD; Haan, J; Meijler, WJ; Timmerman, H; van Coevorden, RS	1
Edvinsson, L; Goadsby, PJ	1
Peroutka, SJ	1
Raskin, NH	1
Van Mil, JW	1
Du, XY; Saxena, PR; Schoemaker, RG; Van Gelderen, EM	1
Castanon, N; Chauveau, J; Chaveau, J; Hen, R; Macor, JE; Moskowitz, MA; Scearce, K; Waeber, C; Yu, XJ	1
Mathew, NT; Ravishankar, K; Sanin, LC	1
Le Force, B; Margul, B; Ricalde, O; Saper, J; Winner, P	1
Ashford, E; Bertin, L; Bès, A; Pilgrim, AJ; Touchon, J	1
Lucker, C; Mathew, NT; Tietjen, GE	1
Lambert, G; Michalicek, J	1
Catarci, T; Cerbo, R	1
Mathew, NT	1
Audinot-Bouchez, V; Chaput, C; Conte, C; Lavielle, G; Lochon, S; Millan, MJ; Newman-Tancredi, A; Verrièle, L	1
Kaplan, B; Swain, RA	1
Björkman, S; Edvinsson, L; Nilsson, F; Nilsson, T; Nordström, CH	1
Steurer, J	1
Bonnafous, R; John, GW; Valentin, JP	1
Finkel, AG; Howard, JF; Mann, JD	1
Becker, WJ; Riess, CM; Robertson, M	1
Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Van Gompel, P; Vanhoenacker, P; Wouters, R	1
Bax, WA; Ferrari, MD; MaassenVanDenBrink, A; Reekers, M; Saxena, PR	1
John, GW; Le Grand, B; Vié, B	1
Kozma, CM; Lawrence, BJ; Payne, K	1
Centurión, D; De Vries, P; Rabelo, G; Sánchez-López, A; Saxena, P; Villalón, CM	1
Logemann, CD; Rankin, LM	1
Lutz, G; Pradalier, A; Vincent, D	1
Ashford, E; Boureau, F; Esperanca, P; Kappos, L; Schoenen, J	1
Tfelt-Hansen, P	2
Krumholz, W; Menges, T; Ogal, H; Szalay, G	1
Hargreaves, RJ; Williamson, DJ	1
Steiner, TJ; Tfelt-Hansen, P	1
Akhtar, ND; Murray, MA; Rothner, AD	1
Rothner, AD	1
Yamane, K	1
Ferrari, MD	1
Autret, A; Mondon, K	1
Diamond, S; Wenzel, R	1
Csiba, L; Ficzere, A	1
Aubel, B; Bourgoin, S; Hamon, M; Kayser, V	1
Vaitkus, A; Vilionskis, A	1
Bigal, ME; Tepper, SJ	1
Markley, HG	1
Andrews, PL; Cheng, FH; Moreaux, B; Ngan, MP; Rudd, JA; Sam, TS; Wai, MK; Wan, C	1
Auvin, S; Cuvellier, JC; Joriot, S; Vallée, L	1
Kabbouche, MA; Linder, SL	1
Berger, MY; Bruijn, JK; Damen, L; Koes, BW; Passchier, J; Verhagen, AP	1
Gano, D; Gerretsen, P; Silver, S	1
Nahas, SJ; Silberstein, SD	1
Autret-Leca, E; Beau-Salinas, F; Bensouda-Grimaldi, L; Cissoko, H; Jonville-Béra, AP	1
Silberstein, SD	1
Detwiler, TJ; Kane, SA; Lynch, JJ; Regan, CP	1
Rothrock, JF	1
Derry, CJ; Derry, S; Moore, RA	1
Peatfield, R	1
Dahlöf, C; Maassen Van Den Brink, A	1
Goadsby, PJ; Mathias, CJ; Viana, M	1
Argüelles, CF; Godínez-Chaparro, B; Granados-Soto, V; López-Santillán, FJ; Villalón, CM	1
Lanteri-Minet, M	1
Chan, KY; Danser, AJ; de Vries, R; Dirven, CM; Kori, SH; Labruijere, S; MaassenVanDenBrink, A; van den Bogaerdt, AJ	1
Ward, TN	1
Charles, A; Goadsby, PJ; Hansen, JM	1

Reviews

34 review(s) available for dihydroergotamine and sumatriptan

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Current treatment of migraine]. Revista clinica espanola, 1992, Volume: 191, Issue:3 Topics: Adult; Child; Dihydroergotamine; Ergotamine; Female; Humans; Indoles; Male; Methysergide; Metoclopramide; Middle Aged; Migraine Disorders; Sulfonamides; Sumatriptan; Time Factors; Vasoconstrictor Agents	1992
[Serotonin agonists and antagonists in migraine]. Pathologie-biologie, 1992, Volume: 40, Issue:4 Topics: Benzoxepins; Contraindications; Cyproheptadine; Dihydroergotamine; Ergotamine; Histamine H1 Antagonists; Humans; Indoles; Methysergide; Migraine Disorders; Phenothiazines; Pizotyline; Receptors, Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents	1992
The trigemino-vascular system and migraine. Pathologie-biologie, 1992, Volume: 40, Issue:4 Topics: Blood Proteins; Calcitonin Gene-Related Peptide; Cerebrovascular Disorders; Cranial Nerve Diseases; Dihydroergotamine; Dura Mater; Humans; Indoles; Migraine Disorders; Receptors, Serotonin; Substance P; Sulfonamides; Sumatriptan; Trigeminal Nerve; Vasoconstrictor Agents	1992
[Treatment of the acute migraine attack]. Revista de neurologia, 1995, Volume: 23 Suppl 2 Topics: Acute Disease; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents	1995
[Status migrainosus]. Revista de neurologia, 1995, Volume: 23 Suppl 2 Topics: Brain; Dihydroergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents	1995
Acute treatment of migraine attacks. Current opinion in neurology, 1995, Volume: 8, Issue:3 Topics: Adolescent; Adult; Analgesics; Child; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Pregnancy; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents	1995
Migraine treatment: the British perspective. Headache, 1994, Volume: 34, Issue:8 Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Sumatriptan; United Kingdom	1994
Overview of diagnosis and treatment of migraine. Neurology, 1994, Volume: 44, Issue:10 Suppl 7 Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Antagonists; Sumatriptan	1994
Recent advances in the acute management of migraine and cluster headaches. Journal of general internal medicine, 1994, Volume: 9, Issue:6 Topics: Analgesics; Butorphanol; Capsaicin; Cluster Headache; Dihydroergotamine; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Sumatriptan; Tolmetin	1994
Therapeutic advances in migraine. Journal of clinical pharmacology, 1993, Volume: 33, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Female; Humans; Indoles; Male; Migraine Disorders; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Valproic Acid	1993
5-Hydroxytryptamine receptor subtypes and the pharmacology of migraine. Neurology, 1993, Volume: 43, Issue:6 Suppl 3 Topics: Adenylyl Cyclases; Dihydroergotamine; Humans; Indoles; Migraine Disorders; Receptors, Serotonin; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan	1993
Acute and prophylactic treatment of migraine: practical approaches and pharmacologic rationale. Neurology, 1993, Volume: 43, Issue:6 Suppl 3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Phenothiazines; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Valproic Acid	1993
[Symptomatic treatment of cluster headache]. Revista de neurologia, 1995, Volume: 23 Suppl 4 Topics: Alkaloids; Analgesics; Capsaicin; Cluster Headache; Cocaine; Dihydroergotamine; Ergotamine; Humans; Lidocaine; Methoxyflurane; Narcotics; Oxygen; Sumatriptan; Vasoconstrictor Agents	1995
Serotonin 1D (5-HT1D) agonists and other agents in acute migraine. Neurologic clinics, 1997, Volume: 15, Issue:1 Topics: Acute Disease; Analgesics, Non-Narcotic; Cluster Headache; Dihydroergotamine; Drug Interactions; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents	1997
Diagnosis, prophylaxis, and treatment of headaches in the athlete. Southern medical journal, 1997, Volume: 90, Issue:9 Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Chronic Disease; Cluster Headache; Dihydroergotamine; Female; GABA Agents; Headache; Humans; Male; Migraine Disorders; Nortriptyline; Physical Exertion; Psychomotor Performance; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sports; Sumatriptan; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil	1997
Newer intranasal migraine medications. American family physician, 2000, Jan-01, Volume: 61, Issue:1 Topics: Administration, Intranasal; Administration, Oral; Analgesics, Non-Narcotic; Clinical Trials as Topic; Dihydroergotamine; Half-Life; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2000
Neurogenic inflammation in the context of migraine. Microscopy research and technique, 2001, May-01, Volume: 53, Issue:3 Topics: Animals; Blood Proteins; Bosentan; Calcitonin Gene-Related Peptide; Capillary Permeability; Dihydroergotamine; Dura Mater; Humans; Migraine Disorders; Narcotics; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT1F; Receptors, Neurokinin-1; Receptors, Serotonin; Serotonin Receptor Agonists; Skull; Sulfonamides; Sumatriptan; Trigeminal Nerve; Vasoconstrictor Agents; Vasodilation	2001
Complicated migraine and migraine variants. Seminars in pediatric neurology, 2001, Volume: 8, Issue:1 Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Diagnosis, Differential; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Sumatriptan	2001
[Migraine: selection of therapeutic agents to be applied during its attack]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2001, Apr-10, Volume: 90, Issue:4 Topics: Analgesics; Antiemetics; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Sumatriptan	2001
Practical approaches to migraine management. CNS drugs, 2002, Volume: 16, Issue:6 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Clinical Trials as Topic; Dihydroergotamine; Humans; Migraine Disorders; Psychotropic Drugs; Secondary Prevention; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents	2002
[Treatment of migraine in patients with hypertension and ischemic heart disease]. Ideggyogyaszati szemle, 2002, Jan-20, Volume: 55, Issue:1-2 Topics: Adjuvants, Pharmaceutic; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Contraindications; Dihydroergotamine; Dopamine Agonists; Ergotamine; Humans; Hypertension; Indoles; Migraine Disorders; Myocardial Ischemia; Oxazolidinones; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents	2002
Ergotamine, dihydroergotamine: current uses and problems. Current medical research and opinion, 2001, Volume: 17 Suppl 1 Topics: Analgesics, Non-Narcotic; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan	2001
[The problems of migraine headache treatment]. Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:7 Topics: Aged; Analgesics; Analgesics, Non-Narcotic; Aspirin; Dihydroergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Stress, Psychological; Sumatriptan; Time Factors; Tryptamines; Vasoconstrictor Agents	2002
Ergotamine and dihydroergotamine: a review. Current pain and headache reports, 2003, Volume: 7, Issue:1 Topics: Dihydroergotamine; Dose-Response Relationship, Drug; Ergotamine; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome	2003
Topical agents in the treatment of cluster headache. Current pain and headache reports, 2003, Volume: 7, Issue:2 Topics: Administration, Intranasal; Administration, Topical; Capsaicin; Cluster Headache; Cocaine; Dihydroergotamine; Humans; Lidocaine; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents	2003
[Pharmacologic treatment of acute migraine attack in children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:3 Topics: Acetaminophen; Acute Disease; Administration, Intranasal; Administration, Oral; Adolescent; Age Factors; Analgesics, Non-Narcotic; Biofeedback, Psychology; Child; Dihydroergotamine; Humans; Ibuprofen; Injections, Intravenous; Life Style; Migraine Disorders; Relaxation Therapy; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents	2005
Acute treatment of pediatric headache in the emergency department and inpatient settings. Pediatric annals, 2005, Volume: 34, Issue:6 Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Child; Dihydroergotamine; Drug Therapy, Combination; Emergency Service, Hospital; Headache; Hospitalization; Humans; Metoclopramide; Serotonin Receptor Agonists; Sumatriptan	2005
Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics, 2005, Volume: 116, Issue:2 Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Child; Child, Preschool; Controlled Clinical Trials as Topic; Dihydroergotamine; Female; Humans; Ibuprofen; Ketorolac; Male; Migraine Disorders; Prochlorperazine; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan	2005
Acute treatment of paediatric migraine: a meta-analysis of efficacy. Journal of paediatrics and child health, 2008, Volume: 44, Issue:1-2 Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Child; Dihydroergotamine; Drug Evaluation; Humans; Ibuprofen; Migraine Disorders; Oxazolidinones; Placebos; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2008
Meeting acute migraine treatment needs through novel treatment formulations. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2010, Volume: 7, Issue:2 Topics: Analgesics, Non-Narcotic; Diclofenac; Dihydroergotamine; Drug Administration Routes; Drug Delivery Systems; Drug Prescriptions; Humans; Migraine Disorders; Sumatriptan	2010
Sumatriptan (intranasal route of administration) for acute migraine attacks in adults. The Cochrane database of systematic reviews, 2012, Feb-15, Issue:2 Topics: Acute Disease; Administration, Intranasal; Adult; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Pain Management; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2012
Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment. Headache, 2012, Volume: 52, Issue:4 Topics: Animals; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Sumatriptan; Treatment Outcome	2012
What's new in the migraine attack treatment. Revue neurologique, 2013, Volume: 169, Issue:5 Topics: Analgesics; Calcitonin Gene-Related Peptide Receptor Antagonists; Dihydroergotamine; Humans; Migraine Disorders; Pain Management; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Transcranial Magnetic Stimulation	2013

Trials

6 trial(s) available for dihydroergotamine and sumatriptan

Article	Year
Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble. Headache, 1993, Volume: 33, Issue:8 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Dihydroergotamine; Double-Blind Method; Drug Interactions; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Sumatriptan	1993
A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Archives of neurology, 1996, Volume: 53, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sumatriptan	1996
A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. Neurology, 1996, Volume: 47, Issue:2 Topics: Administration, Intranasal; Adult; Dihydroergotamine; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Sumatriptan	1996
Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine. A retrospective cost-efficacy analysis. PharmacoEconomics, 1996, Volume: 10, Issue:1 Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; Dihydroergotamine; Humans; Middle Aged; Migraine Disorders; Retrospective Studies; Sumatriptan; Vasoconstrictor Agents	1996
A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine. International journal of clinical practice, 2000, Volume: 54, Issue:5 Topics: Adult; Aged; Belgium; Cross-Over Studies; Dihydroergotamine; Double-Blind Method; Female; France; Humans; Male; Middle Aged; Migraine Disorders; Portugal; Sumatriptan; Switzerland; Vasoconstrictor Agents	2000
Reduced efficacy of sumatriptan in migraine with aura vs without aura. Neurology, 2015, May-05, Volume: 84, Issue:18 Topics: Adult; Databases, Factual; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Migraine with Aura; Migraine without Aura; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents	2015

Other Studies

62 other study(ies) available for dihydroergotamine and sumatriptan

Article	Year
Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. Molecular pharmacology, 1991, Volume: 40, Issue:2 Topics: Amino Acid Sequence; Base Sequence; Cloning, Molecular; Cyclic AMP; GTP-Binding Proteins; Humans; Molecular Sequence Data; Pertussis Toxin; Receptors, Serotonin; Virulence Factors, Bordetella	1991
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. The Journal of biological chemistry, 1993, Nov-05, Volume: 268, Issue:31 Topics: Adenylyl Cyclases; Base Sequence; Cloning, Molecular; DNA Primers; Humans; Molecular Sequence Data; Receptors, Serotonin; Sequence Alignment; Sequence Homology, Amino Acid; Serotonin Antagonists; Serotonin Receptor Agonists; Signal Transduction	1993
Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proceedings of the National Academy of Sciences of the United States of America, 1993, Sep-15, Volume: 90, Issue:18 Topics: Amino Acid Sequence; Animals; Base Sequence; Blotting, Northern; Brain; CHO Cells; Cricetinae; Cyclic AMP; DNA; Genomic Library; Kinetics; Lysergic Acid Diethylamide; Mianserin; Molecular Sequence Data; Multigene Family; Oligodeoxyribonucleotides; Organ Specificity; Rats; Receptors, Serotonin; Restriction Mapping; Serotonin; Serotonin Receptor Agonists; Transfection	1993
Two amino acid differences in the sixth transmembrane domain are partially responsible for the pharmacological differences between the 5-HT1D beta and 5-HT1E 5-hydroxytryptamine receptors. Journal of neurochemistry, 1996, Volume: 67, Issue:5 Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Binding, Competitive; Chlorocebus aethiops; Cloning, Molecular; COS Cells; DNA Primers; Ergolines; Glutamic Acid; Humans; Isoleucine; Kinetics; Ligands; Lysine; Models, Structural; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Protein Structure, Secondary; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Serine; Serotonin; Transfection	1996
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin Molecular pharmacology, 1996, Volume: 50, Issue:6 Topics: Animals; Benzopyrans; Cattle; Cloning, Molecular; Glioma; HeLa Cells; Humans; Mice; Migraine Disorders; Propylamines; Protein Binding; Pyrimidines; Radioligand Assay; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Tritium; Tumor Cells, Cultured; Vasoconstrictor Agents	1996
Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor. Journal of neurochemistry, 1998, Volume: 71, Issue:5 Topics: Adenylyl Cyclases; Amino Acid Substitution; Binding Sites; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Ligands; Lysergic Acid Diethylamide; Mutagenesis, Site-Directed; Mutation; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists	1998
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties. Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 371, Issue:3 Topics: Animals; Benzamides; Brain; Cells, Cultured; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Ligands; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Serotonin Receptor Agonists; Transfection; Tritium	2005
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3 Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs	2013
[Treatment of cluster headache. Recommendations of the German Migraine and Headache Society]. Medizinische Monatsschrift fur Pharmazeuten, 1992, Volume: 15, Issue:5 Topics: Cluster Headache; Combined Modality Therapy; Dihydroergotamine; Ergotamine; Humans; Indoles; Lidocaine; Oxygen Inhalation Therapy; Sulfonamides; Sumatriptan; Vasoconstrictor Agents	1992
5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Brain research, 1992, Jun-26, Volume: 583, Issue:1-2 Topics: Animals; Axons; Dihydroergotamine; Dura Mater; Electric Stimulation; Endothelium, Vascular; Indoles; Male; Mast Cells; Muscle, Smooth, Vascular; Platelet Activation; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sulfonamides; Sumatriptan; Trigeminal Ganglion; Vascular Headaches; Venules	1992
CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. British journal of pharmacology, 1992, Volume: 106, Issue:2 Topics: Animals; Animals, Newborn; Capsaicin; Carrageenan; Dihydroergotamine; Formaldehyde; Gene Expression Regulation, Neoplastic; Guinea Pigs; Immunohistochemistry; In Vitro Techniques; Indoles; Meninges; Nasal Mucosa; Proto-Oncogene Proteins c-fos; Pyridines; Pyrroles; Rats; Sulfonamides; Sumatriptan	1992
Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig. British journal of pharmacology, 1992, Volume: 107, Issue:2 Topics: Animals; Arteriovenous Anastomosis; Dihydroergotamine; Dura Mater; Ergotamine; Hemodynamics; Indoles; Microspheres; Migraine Disorders; Regional Blood Flow; Sulfonamides; Sumatriptan; Swine; Vasoconstrictor Agents	1992
5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy. Headache, 1991, Volume: 31, Issue:4 Topics: Adenylyl Cyclase Inhibitors; Amitriptyline; Animals; Cattle; Caudate Nucleus; Dihydroergotamine; Ergotamine; Indoles; Kinetics; Methysergide; Migraine Disorders; Radioligand Assay; Receptors, Serotonin; Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Verapamil	1991
Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia : an international journal of headache, 1991, Volume: 11, Issue:4 Topics: Animals; Blood Proteins; Calcitonin Gene-Related Peptide; Capillary Permeability; Cerebrovascular Circulation; Cranial Sinuses; Dihydroergotamine; Electric Stimulation; Indoles; Male; Mast Cells; Migraine Disorders; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sulfonamides; Sumatriptan; Trigeminal Ganglion; Vasoconstrictor Agents	1991
The hospital management of severe migrainous headache. Headache, 1991, Volume: 31, Issue:10 Topics: Adolescent; Adult; Aged; Child; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Indoles; Lidocaine; Male; Middle Aged; Migraine Disorders; Retrospective Studies; Sulfonamides; Sumatriptan	1991
Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology, 1991, Volume: 30, Issue:11 Topics: Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Cranial Sinuses; Dihydroergotamine; Dura Mater; Electric Stimulation; Indoles; Male; Rats; Rats, Inbred Strains; Sulfonamides; Sumatriptan; Trigeminal Ganglion; Vasoconstrictor Agents	1991
Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors. British journal of pharmacology, 1991, Volume: 104, Issue:1 Topics: Animals; Arteriovenous Anastomosis; Brain Chemistry; Carotid Arteries; Coronary Circulation; Dihydroergotamine; Dose-Response Relationship, Drug; Ergotamine; Hemodynamics; Indoles; Methiothepin; Muscle, Smooth, Vascular; Oxygen Consumption; Receptors, Serotonin; Sulfonamides; Sumatriptan; Swine; Vasoconstrictor Agents	1991
Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175). Headache, 1989, Volume: 29, Issue:7 Topics: Animals; Cattle; Dihydroergotamine; In Vitro Techniques; Indoles; Radioligand Assay; Rats; Receptors, Neurotransmitter; Receptors, Serotonin; Sulfonamides; Sumatriptan; Swine	1989
Drugs for migraine. The Medical letter on drugs and therapeutics, 1995, Mar-03, Volume: 37, Issue:943 Topics: Adrenergic beta-Antagonists; Analgesics; Dihydroergotamine; Humans; Migraine Disorders; Sumatriptan	1995
[Multiple value of sumatriptan above that of ergot alkaloids still not proven]. Nederlands tijdschrift voor geneeskunde, 1994, Feb-26, Volume: 138, Issue:9 Topics: Coronary Vessels; Dihydroergotamine; Ergotamine; Humans; Sumatriptan	1994
Recommendations for the emergency treatment of migraine headache. Journal of the Tennessee Medical Association, 1994, Volume: 87, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Dexamethasone; Dihydroergotamine; Emergency Medical Services; Humans; Ketorolac; Migraine Disorders; Sumatriptan; Tolmetin	1994
[Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System]. Nederlands tijdschrift voor geneeskunde, 1993, Apr-24, Volume: 137, Issue:17 Topics: Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Vasoconstrictor Agents	1993
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Annals of neurology, 1993, Volume: 33, Issue:1 Topics: Adolescent; Adult; Animals; Blood Vessels; Cats; Cerebrovascular Circulation; Dihydroergotamine; Female; Humans; Indoles; Laser-Doppler Flowmetry; Male; Middle Aged; Migraine Disorders; Neuropeptides; Sulfonamides; Sumatriptan; Trigeminal Ganglion; Vasoconstrictor Agents	1993
[Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System]. Nederlands tijdschrift voor geneeskunde, 1993, Jun-12, Volume: 137, Issue:24 Topics: Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Therapeutic Equivalency; Vasoconstrictor Agents	1993
Carotid blood flow distribution, haemodynamics and inotropic responses following calcitonin gene-related peptide in the pig. European journal of pharmacology, 1995, Sep-15, Volume: 284, Issue:1-2 Topics: Animals; Arteriovenous Anastomosis; Calcitonin Gene-Related Peptide; Carotid Artery, Common; Dihydroergotamine; Heart Atria; Heart Ventricles; Hemodynamics; Humans; In Vitro Techniques; Microspheres; Myocardial Contraction; Sumatriptan; Swine; Vasoconstrictor Agents	1995
5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors. Molecular pharmacology, 1996, Volume: 49, Issue:5 Topics: Animals; Capillary Permeability; Dihydroergotamine; Dipeptides; Mice; Mice, Knockout; Pyridines; Pyrroles; Pyrrolidines; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Ganglion	1996
Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology, 1996, Volume: 46, Issue:5 Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studies; Furosemide; Headache; Humans; Intracranial Pressure; Male; Middle Aged; Migraine Disorders; Obesity; Papilledema; Pseudotumor Cerebri; Sumatriptan	1996
Serotonin syndrome complicating migraine pharmacotherapy. Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:5 Topics: Adult; Autonomic Nervous System Diseases; Dihydroergotamine; Drug Synergism; Female; Gastrointestinal Diseases; Humans; Injections, Intravenous; Injections, Subcutaneous; Lithium; Mental Disorders; Migraine Disorders; Movement Disorders; Serotonin Receptor Agonists; Sumatriptan; Syndrome	1996
Effect of antimigraine drugs on dural blood flows and resistances and the responses to trigeminal stimulation. European journal of pharmacology, 1996, Sep-12, Volume: 311, Issue:2-3 Topics: Animals; Blood Pressure; Carotid Arteries; Cats; Dihydroergotamine; Dose-Response Relationship, Drug; Heart Rate; Injections, Intravenous; Meningeal Arteries; Migraine Disorders; Regional Blood Flow; Sumatriptan; Trigeminal Ganglion; Vascular Resistance; Vasoconstrictor Agents	1996
Subcutaneous dihydroergotamine vs subcutaneous sumatriptan. Archives of neurology, 1996, Volume: 53, Issue:12 Topics: Dihydroergotamine; Humans; Injections, Subcutaneous; Migraine Disorders; Sumatriptan	1996
[The treatment of migraine]. Revista de neurologia, 1997, Volume: 25, Issue:138 Topics: Adrenergic beta-Antagonists; Amitriptyline; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Nicardipine; Nimodipine; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents	1997
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy. Naunyn-Schmiedeberg's archives of pharmacology, 1997, Volume: 355, Issue:6 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Cell Membrane; Cricetinae; Dihydroergotamine; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Lisuride; Methysergide; Migraine Disorders; Piperazines; Piperidines; Pizotyline; Propranolol; Propylamines; Protein Binding; Pyridines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Recombinant Proteins; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1997
Effects of dihydroergotamine and sumatriptan on isolated human cerebral and peripheral arteries and veins. Acta anaesthesiologica Scandinavica, 1997, Volume: 41, Issue:10 Topics: Cerebral Arteries; Cerebral Veins; Dihydroergotamine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Intracranial Pressure; Serotonin Receptor Agonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents	1997
[Critical evaluation of "guidelines"]. Praxis, 1998, Feb-04, Volume: 87, Issue:6 Topics: Adult; Dihydroergotamine; Female; Humans; Migraine Disorders; Practice Guidelines as Topic; Quality Assurance, Health Care; Sumatriptan; Switzerland	1998
Contractile responses evoked by dihydroergotamine, naratriptan and sumatriptan in the canine isolated coronary artery. Fundamental & clinical pharmacology, 1998, Volume: 12, Issue:2 Topics: Animals; Coronary Vessels; Dihydroergotamine; Dogs; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Indoles; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Piperidines; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents	1998
Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications. Headache, 1998, Volume: 38, Issue:4 Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Headache; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Myasthenia Gravis; Recurrence; Serotonin Receptor Agonists; Sumatriptan	1998
Episodic cluster headache in a community: clinical features and treatment. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1998, Volume: 25, Issue:2 Topics: Adaptation, Psychological; Adult; Aged; Analgesics; Cluster Headache; Dihydroergotamine; Emergency Service, Hospital; Female; Hospitals; Humans; Male; Middle Aged; Oxygen; Physicians; Quality of Life; Sleep; Sumatriptan; Surveys and Questionnaires; Tooth Extraction; Vasoconstrictor Agents	1998
Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines. British journal of pharmacology, 1998, Volume: 123, Issue:8 Topics: Adenylyl Cyclases; Animals; Benzopyrans; Cell Line; Cell Membrane; Cloning, Molecular; Dihydroergotamine; Humans; Ligands; Mice; Propylamines; Pyrimidines; Rats; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Sumatriptan; Vasoconstrictor Agents	1998
Coronary side-effect potential of current and prospective antimigraine drugs. Circulation, 1998, Jul-07, Volume: 98, Issue:1 Topics: Adolescent; Adult; Aged; Angina Pectoris; Child; Coronary Vessels; Dihydroergotamine; Ergotamine; Female; Humans; In Vitro Techniques; Indoles; Male; Methysergide; Middle Aged; Migraine Disorders; Piperidines; Sulfonamides; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents	1998
Effects of sumatriptan on coronary flow and left ventricular function in the isolated perfused guinea pig heart. Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:3 Topics: Animals; Coronary Circulation; Diastole; Dihydroergotamine; Endothelium, Vascular; Guinea Pigs; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Oxadiazoles; Oxazoles; Oxazolidinones; Perfusion; Piperazines; Rabbits; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Ventricular Function, Left	1998
New "triptans" and other drugs for migraine. The Medical letter on drugs and therapeutics, 1998, Oct-09, Volume: 40, Issue:1037 Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents	1998
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors. British journal of pharmacology, 1999, Volume: 126, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Flow Velocity; Carotid Arteries; Clonidine; Dihydroergotamine; Dogs; Ergotamine; Female; Hemodynamics; Male; Methysergide; Oxadiazoles; Phenylephrine; Piperazines; Prazosin; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin Antagonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Yohimbine	1999
Transient global amnesia, migraine, thalamic infarct, dihydroergotamine, and sumatriptan. Headache, 2000, Volume: 40, Issue:4 Topics: Amnesia, Transient Global; Brain Infarction; Dihydroergotamine; Female; Humans; Injections, Subcutaneous; Middle Aged; Migraine Disorders; Sumatriptan; Vasoconstrictor Agents	2000
Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies. Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:2 Topics: Dihydroergotamine; Humans; Migraine Disorders; Nebulizers and Vaporizers; Sumatriptan; Vasoconstrictor Agents	2000
[Effect of migraine medications on monocyte chemotaxis] . Anaesthesiologie und Reanimation, 2000, Volume: 25, Issue:4 Topics: Adult; Analgesics; Aspirin; Chemotaxis, Leukocyte; Dihydroergotamine; Humans; Immune Tolerance; Male; Metoclopramide; Metoprolol; Migraine Disorders; Propranolol; Sumatriptan	2000
Sumatriptin vs dihydroergotamine: patient preference. International journal of clinical practice, 2001, Volume: 55, Issue:2 Topics: Administration, Inhalation; Analgesics, Non-Narcotic; Dihydroergotamine; Humans; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Sumatriptan	2001
Status migrainosus in children and adolescents. Seminars in pediatric neurology, 2001, Volume: 8, Issue:1 Topics: Adolescent; Child; Diagnosis, Differential; Dihydroergotamine; Drug Therapy, Combination; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Male; Meperidine; Methylprednisolone; Migraine Disorders; Prednisolone; Sumatriptan	2001
Sumatriptan by injection. Cephalalgia : an international journal of headache, 2001, Volume: 21 Suppl 1 Topics: Clinical Trials as Topic; Dihydroergotamine; Dose-Response Relationship, Drug; Humans; Injections, Subcutaneous; Migraine Disorders; Sumatriptan; Treatment Outcome	2001
[Migraine and facial pain]. La Revue du praticien, 2001, Oct-15, Volume: 51, Issue:16 Topics: Adult; Analgesics; Analgesics, Non-Narcotic; Carbamazepine; Child; Diagnosis, Differential; Dihydroergotamine; Facial Pain; Female; Humans; Male; Methysergide; Middle Aged; Migraine Disorders; Oxygen Inhalation Therapy; Psychotherapy; Serotonin Antagonists; Sumatriptan; Time Factors; Trigeminal Neuralgia; Vasoconstrictor Agents	2001
The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain. British journal of pharmacology, 2002, Volume: 137, Issue:8 Topics: Animals; Dihydroergotamine; Disease Models, Animal; Male; Migraine Disorders; Oxazolidinones; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Nerve Diseases; Tryptamines	2002
Headaches that could spell trouble. Consumer reports, 2004, Volume: 69, Issue:6 Topics: Dihydroergotamine; Headache; Humans; Migraine Disorders; Sumatriptan	2004
Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew). European journal of pharmacology, 2005, Jan-31, Volume: 508, Issue:1-3 Topics: Animals; Antiemetics; Butanols; Capsaicin; Cyclooxygenase Inhibitors; Dihydroergotamine; Diphenhydramine; Diterpenes; Domperidone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Indomethacin; Malates; Methysergide; Metoclopramide; Migraine Disorders; Ondansetron; Piperidines; Ruthenium Red; Scopolamine; Serotonin Antagonists; Serotonin Receptor Agonists; Shrews; Sumatriptan; Time Factors; Tropanes; Vomiting	2005
Triptans: actions and reactions. Headache, 2008, Volume: 48, Issue:4 Topics: Administration, Cutaneous; Administration, Oral; Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Herpes Simplex; Herpesvirus 2, Human; Humans; Migraine Disorders; Neuralgia, Postherpetic; Pyrrolidines; Serotonin Receptor Agonists; Skin; Sumatriptan; Tryptamines	2008
Drug dependence associated with triptans and ergot derivatives: a case/non-case study. European journal of clinical pharmacology, 2010, Volume: 66, Issue:4 Topics: Claviceps; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Risk; Substance-Related Disorders; Sumatriptan; Tryptamines	2010
Effect of calcitonin gene-related peptide receptor antagonism on the systemic blood pressure responses to mechanistically diverse vasomodulators in conscious rats. Journal of cardiovascular pharmacology, 2010, Volume: 56, Issue:5 Topics: Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Carotid Arteries; Dihydroergotamine; Dose-Response Relationship, Drug; Hemodynamics; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sumatriptan; Vasoconstrictor Agents; Vasodilator Agents	2010
Commentary. Headache, 2011, Volume: 51, Issue:4 Topics: Clinical Trials as Topic; Dihydroergotamine; Humans; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Vasoconstrictor Agents	2011
Headache currents commentary. Headache, 2012, Volume: 52, Issue:4 Topics: Analgesics; Animals; Dihydroergotamine; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders; Sumatriptan	2012
Headache in three new cases of Harlequin syndrome with accompanying pharmacological comparison with migraine. Journal of neurology, neurosurgery, and psychiatry, 2012, Volume: 83, Issue:6 Topics: Adult; Aged; Autonomic Nervous System Diseases; Diagnosis, Differential; Dihydroergotamine; Ergotamine; Female; Flushing; Headache; Humans; Hypohidrosis; Middle Aged; Migraine Disorders; Nitroglycerin; Sumatriptan; Vasoconstrictor Agents; Vasodilator Agents	2012
Role of 5-HT₁B/₁D receptors in the reduction of formalin-induced nociception and secondary allodynia/hyperalgesia produced by antimigraine drugs in rats. Life sciences, 2013, Jun-13, Volume: 92, Issue:22 Topics: Acute Pain; Animals; Biphenyl Compounds; Chronic Pain; Dihydroergotamine; Disease Models, Animal; Drug Therapy, Combination; Female; Formaldehyde; Hyperalgesia; Methysergide; Nociceptive Pain; Piperazines; Piperidones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin Antagonists; Spiro Compounds; Sumatriptan	2013
Dihydroergotamine and sumatriptan in isolated human coronary artery, middle meningeal artery and saphenous vein. Cephalalgia : an international journal of headache, 2015, Volume: 35, Issue:2 Topics: Adolescent; Adult; Aged; Coronary Vessels; Dihydroergotamine; Female; Humans; Male; Meningeal Arteries; Middle Aged; Organ Culture Techniques; Saphenous Vein; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Young Adult	2015
Does the presence of aura inform us regarding migraine severity and response to treatment? Neurology, 2015, May-05, Volume: 84, Issue:18 Topics: Dihydroergotamine; Female; Humans; Male; Migraine with Aura; Migraine without Aura; Sumatriptan; Vasoconstrictor Agents	2015